Aktiesnakken — April 2011
-
mornings
-
nu må vi se om novo kan holde dampen oppe
-
nej det er rigtigt, Novo skuffer aldrig
-
-
23% er flot...men pas en smule på multiplerne
-
prøv at se side 4. Deres andel af insulin markedet er jo ondt stort
-
ja det er rigtigt imponerende
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind